Issue 17 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

22

No.

17

April 26, 1996Apr 26, 1996

Free

DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

Centers May Become More specialized, Klausner Tells AACI

NIH, NCI Being Discussions With HCFA On Reimbursement

Recent Issues

Volume 51 | Issue 32 - September 05, 2025

Volume 51 | Issue 31 - August 08, 2025

Volume 51 | Issue 30 - August 01, 2025

Volume 51 | Issue 29 - July 25, 2025

Volume 51 | Issue 28 - July 18, 2025

Volume 51 | Issue 27 - July 11, 2025